Background
It is now well established that mental health disorders are heritable [1]. Genetic counselling is a process through which a trained professional helps an individual to better understand and adapt to the medical, psychological, and familial implications of genetic contributions to disease [2]. As of yet, no genetic tests to confirm a psychiatric diagnosis exist and alone they are unlikely to be sufficient for diagnosis. However, a formal genetic test is not required for the delivery of genetic counselling and for the benefits to be realised [3]. Psychiatric genetic counselling is conceptually identical to genetic counselling for other types of disorders and its efficacy for adults diagnosed with psychiatric disorders and their family members has been documented [4]. We are now entering an era in which genetic information is likely to become far more available as it is gradually integrated into healthcare. Thus, how to effectively communicate complex genetic risk information is of high research priority.
Communicating genetic risk for psychiatric disorders comes with many challenges due to their complex and multifactorial nature. Nonetheless, psychiatric genetic counselling is associated with a number of positive immediate and long-term outcomes [4]. For instance, psychiatric genetic counselling can tackle misconceptions about causes of illness, address genetic and/or environmental determinism, empower and reduce shame and/or guilt, change one’s approach to treatment, and enable more informed decision-making regarding major life decisions, such as having children [4]. Such established benefits suggest that psychiatric genetic counselling will become an important part of clinical care for psychiatric patients in the future.
Half of mental health disorders start before the age of 14 [5], with 1 in 7 young people between 10 to 19 years old experiencing mental ill health [6]. Thus, childhood or adolescence could be a particularly suitable window within which to receive psychiatric genetic counselling. This may prevent misconceptions about the causes of one’s mental illness, manage stigmatising beliefs related to personal or family history of mental health problems [7], and encourage risk-reducing behaviours [8, 9]. Psychiatric genetic counselling could also have a positive impact on parents and caregivers, who often feel responsible for their child’s mental health and may experience feelings of guilt, shame, or a heavy burden of responsibility [10]. Such feelings may be partially rooted in a limited understanding of the contributions of genetic and environmental factors to mental disorders [11]. This can have a variety of negative behavioural consequences such as not seeking out suitable support for their child or potentially limiting the number of their future children [12, 13].
Lack of research into the communication of genetic risk information to children and adolescents
Research exploring physical health conditions in young people highlights a strong desire to better understand the cause/s of their diagnosed disorder [14, 15]. Given the complex nature of psychiatric disorders, genetic counsellors recognise that children and adolescents require specific tools and techniques to adequately comprehend information about the aetiology and management of their condition. For example, adapting the wording of medical terminology or using metaphors and visual aids may prove beneficial [16]. A mixed-method systematic review analysing the literature on genetic counselling for children and adolescents identified a dearth of publications on how best to communicate this type of information to children and adolescents (Radu M, Moldovan R. Genetic counseling for children and adolescents: A mixed-method systematic review. 2022. Manuscript in preparation.). The authors noted the stark contrast between the large number of guidelines and recommendations available and the relatively scarce number of empirical research studies. The picture is even less clear for psychiatric disorders. Furthermore, to this day, studies investigating the efficacy of psychiatric genetic counselling have focussed on adults only [17].
Research directions and practical recommendations
We propose the following research priorities:
-
1.
What is the most effective way to communicate personal genetic risk to children and adolescents?
Young people form a distinct patient group and may need specific strategies or tools to explain the concept of inherited genetic risk for psychiatric disorders. For instance, the ‘mental health jar’ has proved to be extremely successful within adults with psychiatric disorders [8]. However, traditional communication styles used with adults may not be directly translatable to young people. Research now needs to investigate whether this tool (and others) are similarly successful in young populations. Furthermore, given that genetic information may have implications for other family members, genetic counsellors can support individuals when they are adapting to the medical, psychological, and familial implications of their condition [17].
-
2.
When is the most appropriate time to discuss risk for psychiatric disorders with young people?
Young people want to learn about their physical disorders at a much younger age than when genetic counselling is routinely offered [14, 15]. As most research has focused on physical health conditions or on adults with psychiatric conditions, the effectiveness of psychiatric genetic counselling in younger age groups is still unclear. Further, communication requirements may differ depending on the specific developmental stage within childhood and adolescence, or indeed the psychiatric problems experienced. A recent qualitative study explored the opinions of ten parents of children with the genetic condition 22q11.2 deletion syndrome and highlighted that the child’s developmental age and thus ability to comprehend complex information influenced when they decided to initiate discussions about the cause of the disorder [18]. Similar types of research are required to establish the optimal age period within childhood and/or adolescence during which psychiatric genetic counselling is most effective for a range of disorders.
-
3.
Who is best placed to offer this service?
Given the prevalence of mental illnesses and the relative dearth of genetic counsellors (which falls far below the recommendations by the WHO), a focused effort to train other healthcare professionals may reduce reliance on genetic counsellors. A meta-analysis found that the type of professional, i.e., genetic counsellors versus other specialists, had no significant impact on the association between psychiatric genetic counselling and positive outcomes in adults, such as reductions in anxiety or guilt and increase in empowerment or self-efficacy [4]. However, more research is needed to understand the ability of other specialists to fulfil this role effectively within child and adolescent services after adequate training. Some argue that all medical professionals who interact with psychiatric patients may be required to initiate discussions about genetic and environmental risk. As such, there is an argument for mainstreaming psychiatric genetic counselling into healthcare. This has garnered more attention over the years as genetic testing becomes more commonplace but, regardless of the setting in which it is offered, it will be important for psychiatric genetic counselling to be delivered in an evidence-based manner [11] and will require integration into their professional training.
Conclusion
Psychiatric genetic counselling holds great potential for benefiting children and adolescents experiencing mental health disorders, as well as their parents/caregivers. While children and adolescents want to better understand the cause of their disorder/s, little empirical research has been conducted on the communication of genetic information to this distinct patient group. Therefore, we propose that investigating how to best address psychiatric disorders and deliver genetic information to children and adolescents must become a research priority in order to support and inform evidence-based practice and guidelines.
References
Polderman TJC, Benyamin B, de Leeuw CA, Sullivan PF, van Bochoven A, Visscher PM, et al. Meta-analysis of the heritability of human traits based on fifty years of twin studies. Nat Genet. 2015;47:702–9.
Resta R, Biesecker BB, Bennett RL, Blum S, Hahn SE, Strecker MN, et al. A new definition of genetic counseling: National Society of Genetic Counselors’ task force report. J Genet Couns. 2006;15:77–83.
Moldovan R, McGhee KA, Coviello D, Hamang A, Inglis A, Ingvoldstad Malmgren C, et al. Psychiatric genetic counseling: A mapping exercise. Am J Med Genet B Neuropsychiatr Genet. 2019;180:523–32.
Moldovan R, Pintea S, Austin J. The efficacy of genetic counseling for psychiatric disorders: a meta-analysis. J Genet Couns. 2017;26:1341–7.
Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:593–602.
World Health Organisation. Adolescent mental health. World Health Organisation 2021. https://www.who.int/news-room/fact-sheets/detail/adolescent-mental-health (accessed April 14 2022).
Hinshaw SP, Stier A. Stigma as related to mental disorders. Annu Rev Clin Psychol. 2008;4:367–93.
Semaka A, Austin J. Patient perspectives on the process and outcomes of psychiatric genetic counseling: An “Empowering Encounter”. J Genet Couns. 2019;28:856–68.
Sabatello M, Chen Y, Herrera CF, Brockhoff E, Austin J, Appelbaum PS. Teenagers and precision psychiatry: a window of opportunity. Public Health Genomics. 2021;24:14–25.
Radu M, Ciucă A, Crișan C-A, Pintea S, Predescu E, Șipos R, et al. The impact of psychiatric disorders on caregivers: An integrative predictive model of burden, stigma, and well-being. Perspect Psychiatr Care 2022. https://doi.org/10.1111/ppc.13071.
Austin JC. Evidence-based genetic counseling for psychiatric disorders: a road map. Cold Spring Harb Perspect Med. 2020;10. https://doi.org/10.1101/cshperspect.a036608.
Meiser B, Mitchell PB, Kasparian NA, Strong K, Simpson JM, Mireskandari S, et al. Attitudes towards childbearing, causal attributions for bipolar disorder and psychological distress: a study of families with multiple cases of bipolar disorder. Psychol Med. 2007;37:1601–11.
Austin JC, Hippman C, Honer WG. Descriptive and numeric estimation of risk for psychotic disorders among affected individuals and relatives: implications for clinical practice. Psychiatry Res. 2012;196:52–6.
Pichini A, Shuman C, Sappleton K, Kaufman M, Chitayat D, Babul-Hirji R. Experience with genetic counseling: the adolescent perspective. J Genet Couns. 2016;25:583–95.
Szybowska M, Hewson S, Antle BJ, Babul-Hirji R. Assessing the informational needs of adolescents with a genetic condition: what do they want to know? J Genet Couns. 2007;16:201–10.
Duncan RE, Young M-A. Tricky teens: are they really tricky or do genetic health professionals simply require more training in adolescent health? Per Med. 2013;10:589–600.
Ryan J, Virani A, Austin JC. Ethical issues associated with genetic counseling in the context of adolescent psychiatry. Appl Transl Genom. 2015;5:23–9.
Cook CB, Slomp C, Austin J. Parents’ perspectives, experiences, and need for support when communicating with their children about the psychiatric manifestations of 22q11.2 deletion syndrome (22q11DS). J Community Genet. 2022;13:91–101.
Funding
Jessica Mundy acknowledges funding from the Lord Leverhulme charitable grant as part of a Ph.D. studentship. Helena L Davies acknowledges funding from the Economic and Social Research Council (ESRC) as part of a Ph.D. studentship. Professor Eley and Professor Breen are part-funded by a program grant from the UK Medical Research Council (MR/V012878/1) and the NIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust. Dr. Vassos also acknowledges funding from the NIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust. The views expressed in this commentary are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health and Social Care. Professor Moldovan acknowledges funding from NHS North West Genomic Medicine Service Alliance, Health Education England and IS-BRC-1215-20007/Manchester NIHR BRC.No other authors acknowledge sources of funding.
Author information
Authors and Affiliations
Contributions
Conceptualization: JM, HLD, TCE, RM. Investigation: JM, HLD, RM, Project administration: JM, HLD, RM, Supervision: EV, TCE, GB, RM Writing – original draft: JM, HLD, Writing—review & editing: JM, HLD, MR, JA, EV, TCE, GB, RM.
Corresponding author
Ethics declarations
Competing interests
Prof. Breen has received honoraria, research or conference grants, and consulting fees from Illumina, Otsuka, and COMPASS Pathfinder Ltd. No. other authors declare conflicts of interest.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Mundy, J., Davies, H.L., Radu, M. et al. Research priorities in psychiatric genetic counselling: how to talk to children and adolescents about genetics and psychiatric disorders. Eur J Hum Genet 31, 262–264 (2023). https://doi.org/10.1038/s41431-022-01253-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41431-022-01253-0